Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Michael Schenke"'
Autor:
Cristina Maria Popa, Irina Florina Cherciu Harbiyeli, Ana Maria Ciurea, Irina Mihaela Cazacu, Simona Laura Ianosi, Michael Schenker, Adrian Saftoiu
Publikováno v:
Gastroenterology Insights, Vol 15, Iss 2, Pp 505-518 (2024)
The introduction of molecularly targeted therapies, particularly the epidermal growth factor receptor inhibitors (EGFRIs), has had a positive impact by increasing the life expectancy of patients with advanced colorectal cancer (CRC). The most used an
Externí odkaz:
https://doaj.org/article/830a2a814d514fa99460078436f0da63
Autor:
Alexandra Leary, Paolo A Ascierto, Michele Maio, Georgia Kollia, Jennifer Friedmann, Marina Tschaika, Patrick Schöffski, Jonathan Baden, Neeltje Steeghs, Parul Doshi, Massimo Di Nicola, Jean-Pierre Delord, Iwona Lugowska, Mauricio Burotto, David S P Tan, Anthony Gonçalves, Michael Schenker, Ning Huang, Tudor-Eliade Ciuleanu, Martin Richardet, Lorena Lupinacci, Julieta Grasselli, Jacqueline Vuky, Somasekhar Konduru, Sai Vikram Vemula, Ruta Slepetis, Misena Pacius, Quyen Duong
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 8 (2024)
Background Checkpoint inhibitor therapy has demonstrated overall survival benefit in multiple tumor types. Tumor mutational burden (TMB) is a predictive biomarker for response to immunotherapies. This study evaluated the efficacy of nivolumab+ipilimu
Externí odkaz:
https://doaj.org/article/be397a2c9d104c41b010a59bc9500941
Autor:
Sun Min Lim, Solange Peters, Ana Laura Ortega Granados, Gustavo dix Junqueira Pinto, Christian Sebastián Fuentes, Giuseppe Lo Russo, Michael Schenker, Jin Seok Ahn, Martin Reck, Zsolt Szijgyarto, Neda Huseinovic, Eleftherios Zografos, Elena Buss, Neda Stjepanovic, Sean O’Donnell, Filippo de Marinis
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-12 (2023)
Abstract PERLA is a global, double-blind, parallel phase II trial (NCT04581824) comparing efficacy and safety of anti–PD-1 antibodies dostarlimab and pembrolizumab, plus chemotherapy (DCT and PCT, respectively) as first-line treatment in patients w
Externí odkaz:
https://doaj.org/article/6e906fdccdde435787415eaa66c8249f
Autor:
Enriqueta Felip, David P. Carbone, Martin Reck, Luis Paz-Ares, Yong Yuan, Nan Hu, Niels Reinmuth, Xiaoqing Zhang, Thomas John, Ying Cheng, Shun Lu, Manuel Cobo, Michael Schenker, Tudor-Eliade Ciuleanu, Stéphanie Bordenave, Oscar Juan-Vidal, Juliana Menezes, Eduardo Richardet, Hideaki Mizutani, Bogdan Zurawski, Aurelia Alexandru, Javed Mahmood, Tuli De, Irene Santi, John R. Penrod, Adam Lee
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 2 (2024)
Background In CheckMate 9LA, nivolumab plus ipilimumab with chemotherapy prolonged overall survival (OS) versus chemotherapy regardless of tumor PD-L1 expression or histology. We report updated efficacy and safety in all randomized patients with a mi
Externí odkaz:
https://doaj.org/article/c372aee3045841d7bf925f1ae98c8480
Autor:
Lucian Dragoș Bratu, Michael Schenker, Puiu Olivian Stovicek, Ramona Adriana Schenker, Alina Maria Mehedințeanu, Tradian Ciprian Berisha, Andreas Donoiu, Stelian Ștefăniță Mogoantă
Publikováno v:
Medicina, Vol 60, Iss 4, p 656 (2024)
Background and Objective: In the therapeutic strategy of rectal cancer, radiotherapy has consolidated its important position and frequent use in current practice due to its indications as neoadjuvant, adjuvant, definitive, or palliative treatment. In
Externí odkaz:
https://doaj.org/article/d7fc8f62f4d844ee9aeaff5aec183246
Autor:
Hans Rischel, Michael Schenke, He Jifeng, Martin Fränzle, Anders P. Ravn, Ernst-Rüdiger Olderog, Markus Müller-Olm, Michael R. Hansen, C. A. R. Hoare
Publikováno v:
Lecture Notes in Computer Science ISBN: 9783540584681
FTRTFT
FTRTFT
As computers increasingly control the systems and services we depend upon within our daily lives like transport, communications, and the media, ensuring these systems function correctly is of utmost importance. This book consists of twelve chapters a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c832c90f5eb621ec497d40bb6b9c89fb
https://ora.ox.ac.uk/objects/uuid:5b69534d-b9d9-45b6-95e2-c7f81255f15f
https://ora.ox.ac.uk/objects/uuid:5b69534d-b9d9-45b6-95e2-c7f81255f15f
Autor:
Michael Schenke
Publikováno v:
Acta Informatica. 36:67-96
In the two parts of this article we present a transformational approach to the design of real-time systems. The overall starting point are requirements formulated in a subset of Duration Calculus called implementables and the target are programs in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09b99964a678cde21d86199fecdd9502
https://doi.org/10.1007/s002360050154
https://doi.org/10.1007/s002360050154
Autor:
Michael Schenke, Ernst-Rüdiger Olderog
Publikováno v:
Acta Informatica. 36:1-65
In the two parts of this article a transformational approach to the design of distributed real-time systems is presented. The starting point are global requirements formulated in a subset of Duration Calculus called implementables and the target are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f596807a780449e5f259e9e6e6c027f9
https://doi.org/10.1007/s002360050153
https://doi.org/10.1007/s002360050153
Autor:
Camil Ciprian Mireștean, Mihai Cosmin Stan, Michael Schenker, Constantin Volovăț, Simona Ruxandra Volovăț, Dragoș Teodor Petru Iancu, Roxana Irina Iancu, Florinel Bădulescu
Publikováno v:
Diagnostics, Vol 13, Iss 16, p 2620 (2023)
Prognosis in recurrent/metastatic head and neck squamous-cell carcinoma (HNSCC) refractory to platinum-based chemotherapy is poor, making therapy optimization a priority. Anti-programmed cell death protein 1 (anti-PD-1) monoclonal antibody Nivolumab
Externí odkaz:
https://doaj.org/article/e9598733e8e942289a0359c6ac798936